Biohaven posted a video "Kv7 Activation" on VIMEO
BHV-7000, a Kv7 activator, is the lead indication for Biohaven in refractory focal epilepsy. Learn more: biohaven.com/pipeline/clinical-programs/kv7/.
See Video »
Biohaven is a Connecticut-based pharmaceutical company that researches and develops novel drugs for the treatment of neurological and neuropsychiatric diseases.
Read more